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Immunohistochemical staining of human skin speci-
men showed the stronger localization of proopio-
melanocortin peptides near the suprabasal layer of the
epidermis, where keratinocytes are mostly differenti-
ated. To test the possibilities of whether the production
of proopiomelanocortin peptides or their receptor-
binding activity or both is increased during differenti-
ation of keratinocytes, we treated the cells in culture
with Ca2F to induce their differentiation. The produc-
tion of proopiomelanocortin peptides and its gene
expression were not induced significantly, but the
Proopiomelanocortin (POMC) is a 31,000 Da pro-hormone that can be processed post-translationallythrough enzymatic cleavage, into adrenocorticotropichormone (ACTH) (α,β,γ)-melanocyte-stimulating hor-mone (MSH) (Oates et al, 1988), corticotropin-like
protein (CLIP), β-endorphin, and β-lipotropin (LPH) (Mains et al,
1977; Liotta et al, 1978). The POMC peptides have numerous
biologic effects on the skin. For instance, α-MSH, ACTH, and
β-LPH have been shown to stimulate sebaceous glands (Thody
and Shuster, 1989). It is well documented that α-MSH and ACTH
interact with different cytokines and have immunomodulatory and
anti-inflammatory actions (Catania and Lipton, 1993; Bhardwaj
and Luger, 1994). The MSH and ACTH peptides are, however,
best known for their actions on melanogenesis (Slominski et al,
1993a; Hunt et al, 1995; Wintzen and Gilchrest, 1996; Luger et al,
1997; Wakamatsu et al, 1997).
Historically, POMC was considered to be produced solely by
pituitary cells (Inoue et al, 1979; Allen, 1916; Atwell, 1916);
however, it has become apparent that POMC mRNA or POMC-
derived peptides are expressed in extrapituitary tissues including
skin (Tsong et al, 1982; Thody et al, 1983; Lolait et al, 1986;
Autelitano et al, 1989; Lunec et al, 1990; Slominski, 1991; Farooqui
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binding ability of melanocortin receptor, as well as its
gene expression were stimulated by Ca2F. Ultraviolet
B irradiation, an inducer of differentiation, stimulated
both proopiomelanocortin production and melano-
cortin receptor expression. These data show that nor-
mal human keratinocytes express melanocortin
receptor similar to melanocytes, and that it is induced
during differentiation. Key words: Ca2F/human epi-
dermis/melanocyte-stimulating hormone receptor/ultraviolet
B. J Invest Dermatol 112:853–860, 1999
et al, 1993; Slominski et al, 1993a,b; Schauer et al, 1994; Chakraborty
et al, 1995, 1996; Iyengar, 1995; Wintzen and Gilchrest, 1996;
Kippenberger et al, 1997). For example, Slominski et al (1992,
1995) for the first time reported the expression of the POMC gene
in mouse and human skin. They also have shown the existence of
POMC-derived peptides in 24 of 39 human skin biopsy specimens
examined (Slominski et al, 1993a, b). In fact, keratinocytes as well
as melanocytes have been found to produce and release these
peptides in culture (Lunec et al, 1990; Farooqui et al, 1993; Schauer
et al, 1994; Chakraborty et al, 1995, 1996; Liu and Johansson,
1995; Wintzen and Gilchrest, 1996; Kippenberger et al, 1997).
Thus in skin POMC peptides might play a part in both cutaneous
melanogenesis and the skin immune system as hormones as well as
through paracrine and/or autocrine mechanisms.
Normal keratinocytes constitutively produce very low levels of
α-MSH and ACTH unless it is stimulated by ultraviolet (UV)
light, tumor promoters (phorbol myristate acetate, PMA), or
interleukin-1 (IL-1), etc. (Schauer et al, 1994). Immunohistochemi-
cal staining of human skin specimen also showed the stronger
localization of POMC peptides near the suprabasal layer of the
epidermis (Nagahama et al, 1998), indicating that either the
production of POMC peptides or their receptor-mediated binding
or both may be increased in association with the differentiating
state of keratinocytes. Although the specific binding sites for
α-MSH are reported to be expressed on keratinocytes1 (Birchall
1Bhardwaj RS, Becher E, Mahnke K, Hartmeyer M, Scholzen T,
Schwarz T, Luger TA: Evidence of the expression of a functional
melanocortin receptor by human keratinocytes. J Invest Dermatol 106:817,
1996 (abstr.)
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et al, 1991; Chakraborty and Pawelek, 1993), contradictory results
have also been found by Suzuki et al (1996) who reported that
unlike melanocytes, normal human epidermal keratinocytes lacked
melanocortin receptor (MC1-R) mRNA. Two recent findings
indicating the presence and function of MSH receptor on normal
human epidermal keratinocytes (Jiang et al, 1997; Orel et al, 1997),
prompted us to re-investigate the MSH receptor activity in normal
human keratinocytes under different experimental conditions. Our
results indicate that the increased expression of POMC peptides
on the differentiated keratinocytes are due to increased binding of
the peptides possibly through increased MC1-R expression.
MATERIALS AND METHODS
Skin samples These were obtained from children and young adults
undergoing surgery and used for the culture of keratinocytes as previously
described (Funasaka and Ichihashi, 1997) and for the immunocyto-
chemical studies.
Cell culture Keratinocytes were cultured in keratinocyte-serum free
medium (keratinocyte-SFM, GIBCO, Life Technologies, Grand Island,
NY) containing 25 µg per ml bovine pituitary extract, and 5 ng per ml of
recombinant epidermal growth factor (rEGF). Antibiotics, streptomycin-
penicillin (40 IU per ml), and fungizone (1.25 µg per ml) were added to
the medium. Second or third passages of the keratinocytes were used for
the following experiments.
Ca2F treatment To induce differentiation, cells were switched to culture
medium containing an increased concentration of Ca21, 1.8 mM, and
maintained for different periods of time (Pillai et al, 1988; Sharpe et al,
1989; Yuspa et al, 1989).
Immunohistochemistry Tissues were fixed in paraformaldehyde,
embedded in paraffin, and sectioned. Deparafinized sections were incubated
with the rabbit polyclonal antibodies IHC7251 and IHC8740 (Peninsula
Laboratory, Belmont, CA) directed against α-MSH, and ACTH, respect-
ively, followed by the avidin–biotin–peroxidase detection system (Dako
LSAB Kit, Dako, Kyoto, Japan), with 3-amino-9-ethylcarbazole as chrom-
ogen (Ohashi et al, 1996). IHC7251 has almost no cross-reactivity (,0.02%)
to β-MSH, γ3-MSH, ACTH, β-endorphin, Met-enkephalin, α-endorphin,
and γ-endorphin, and reacts with α-MSH at 100% specificity. IHC8740
has no cross-reactivity with α-MSH and β-endorphin, but reacts 100%
with ACTH.
The antibodies were diluted in phosphate-buffered saline (PBS) plus
0.1% Triton X-100 at the ratio of 1:1000 and incubated overnight at 4°C.
Normal rabbit serum (Antibodies, Davis, CA) was used as a negative control.
Exposure to UV light Cells were seeded at a subconfluent density in
six-well Costar tissue culture plates for radioimmunoassay of α-MSH and
ACTH and binding assay, and in 75 cm2 flasks for reverse transcription–
polymerase chain reaction (reverse transcription–PCR) and northern
blotting. UVB treatment was performed when the cultures became 70%–
80% confluent. During UVB irradiation, the culture medium was replaced
with 0.3 ml PBS for six-well plates and 1 ml for 75 cm2 flasks. Dosages
of 25 and 50 mJ per cm2 UVB light were irradiated (wavelength range of
260–380 nm with a peak at 302 nm; UVM-57 LAMP, UVP Inc., Upland,
CA). Immediately after phototreatment, PBS was removed and the cells
were incubated with serum-free keratinocyte basal medium with or without
pituitary extracts or rEGF for 12 or 24 h at 37°C in a 5% CO2 atmosphere.
After 24 h, the media were collected from quadruplicate cultures, pooled
separately for each conditions tested, and processed for extraction of POMC
peptides. Cells were collected by minimal trypsin treatment for cell count,
extraction of POMC peptides, RNA isolation, and MSH receptor binding
assay. Cell viability was determined by Trypan Blue exclusion.
Immunostaining for involucrin Monoclonal antibody specific to invo-
lucrin (Biomedical Technologies, Stoughton, MA) was used to immunostain
the differentiated keratinocytes. Cells were cultured in eight well chamber
slide (Nunc, Naperville, IL) and treated with 1.8 mM Ca21, or 25 mJ per
cm2 and 50 mJ per cm2 of UVB, fixed with 3% formaldehyde and stained
with mouse anti-human involucrin antibody (1:20) following the method
provided by the manufacturer of the immunostaining kit.
Extraction of POMC peptides For extraction of peptides, conditioned
culture media were pooled separately for each condition tested, and protease
inhibitors (aprotinin, 0.01%; phenylmethylsulfonyl fluoride 1 mM) were
added, and the media were centrifuged at 16,000 3 g for 30 min. The
supernatants were collected, and according to the manufacturer’s protocol
(Peninsula Laboratory), peptide extraction was carried out as follows. An
equal volume of peptide extraction buffer A (provided with the kit,
Peninsula Laboratory), containing 0.1% triflouroacetic acid, was added and
centrifuged at 3000 3 g for 10 min at 4°C. The supernatants were then
passed through a pre-equilibrated SEP-column containing 200 mg of C18
(Peninsula Laboratory). After washing the column with buffer A, the
peptides were eluted with 3 ml of buffer B (60% acetonitrile in 0.1%
triflouroacetic acid). The eluates were concentrated to dryness in a
centrifugal concentrator. The residues were dissolved in 500 ml of radio-
immunoassay buffer (NaH2PO4, 19 mM; Na2HPO4, 81 mM; pH 7.4;
NaCl, 0.05 M; bovine serum albumin, 0.1%; Triton X-100, 0.1%; NaN3,
0.01%) for the assays of α-MSH and ACTH by the kit method (Peninsula
Laboratory).
Cell pellets were dissolved in 1 ml radioimmunoassay buffer supplemented
with 1% Triton X-100 and phenylmethylsulfonyl fluoride (1 mM), and
aprotinin (0.01%), and processed as above for peptide isolation through
the SEP column.
Radioimmunoassays of a-MSH and ACTH The assay was done
using a commercial radioimmunoassay kit (Peninsula Laboratory). The
antisera are highly specific as the cross-reactivities among the POMC
peptides, such as desacetyl-α-MSH, diacetyl-α-MSH, and deamido-α-
MSH, β-MSH, γ-MSH, ACTH, α,β,γ-endorphin, were less than 0.01%
for rabbit anti-α-MSH according to the kit’s specifications, and as measured
directly with the peptide standards in our laboratory. Likewise rabbit anti-
ACTH (1–24) serum does not cross-react with other POMC peptides,
such as ACTH (1–10), ACTH (1–13), and α-MSH (cross-reactions were
less than 0.01%), but shows 100% reactivity with human ACTH (1–24)
and ACTH (1–39). Assay procedures were followed according to the kit’s
instructions. Briefly, 100 µl of the dissolved material was incubated for
24 h with the antibody against α-MSH and ACTH followed by re-
incubation with 125I-α-MSH or 125I-ACTH for the next 24 h. The bound
125I-peptide was precipitated with goat anti-rabbit IgG (GARGG) and
normal rabbit serum. The tubes were then centrifuged at 3000 3 g for
20 min at 4°C. The supernatants were discarded and pellets were counted
in a gamma counter. The concentrations of the α-MSH and ACTH were
estimated according to the standard curves prepared for both peptides, in
which known quantities of purified α-MSH and ACTH were used to
compete for 125I-α-MSH and 125I-ACTH binding to the antibodies. Values
of α-MSH and ACTH content were normalized to cell number. Levels
were expressed as pg per 0.5 3 106 cells or pg per ml medium for
intracellular and culture medium levels, respectively. The experiment was
repeated three times in quadruplicate, and for statistical analysis the values
were calculated as a percentage of control.
α-MSH binding assay 125I-labeled α-MSH (Peninsula Laboratory) was
used as a ligand, and binding assay was done as described previously
(Chakraborty et al, 1991). Briefly, the normal human keratinocytes were
incubated with 90,000 cpm radioligand per 600 µl incubation buffer (NaCl,
140 mM; KCl, 5 mM; Na2HPO4, 10 mM; KH2PO4, 1 mM; glucose,
0.1%) at 10°C for 2 h. Non-specific binding was assessed by addition of
2 µM unlabeled α-MSH. After incubation, the plates were put on ice and
washed three times with ice-cold PBS(–). Cells were detached with 1 ml
of 1 M NaOH and γ-counted. Specific counts were evaluated by subtracting
the nonspecific counts from the total counts.
Reverse transcription–PCR Total RNA was extracted using the
ISOGEN solution (Nippon Gene, Toyama, Japan) following the manufac-
turer’s kit. For the reverse transcription–PCR assays 5 µg of total RNAs
were reverse transcribed using oligo (dT) as primers and Moloney Murine
Leukemia Virus ReverseTranscriptase (GIBCO-BRL, Life Technolgies,
NY). For quantitative PCR, a control gene, β-actin, was amplified using
primers and conditions described by Lahm et al (1995). Only samples that
proved to be free from DNA contamination by running PCR amplification
with β-actin primers without prior reverse transcription were used for the
experiments. Oligonucleotides used were (a) 59-GAG GGC AAG CGC
TCC TAC TCC-39 (sense), and 59-GGG GCC CTC GTC CTT CTT
CTC-39 (anti-sense) for POMC (Slominski et al, 1995), and (b) 59-GCC
ACC ATG CCA AGA ACC-39 (sense) and 59-ATA GCC AGG AAG
AAG CCA-39 (anti-sense) for MC1-R (Bhardwaj et al, 1997).
Samples for PCR contained 5 µl of the cDNA (corresponding to 0.5 µg
of total RNA), 25 units per ml AmpliTaq DNA polymerase (Perkin-
Elmer), 10 mM Tris–HCl (pH 8.3), 50 mM KCl, 1.5 mM MgCl2, dATP,
dCTP, dGTP, dTTP (200 µmol each), and 100 pmol of the sense and
anti-sense primer. The final reaction volume was 50 µl. Samples were
heated for 5 min at 94°C and then amplified in 30 cycles at 94°C, 55°C
(for POMC) or 51°C (for MC1-R) and 72°C (45 s each). After a final
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extension at 72°C for 10 min, 10 µl of the PCR products were separated
in a 1.5% agarose gels, stained with ethidium bromide and photographed
under UV.
Northern blot analysis For UVB experiment, cells were collected 12
and 24 h after irradiation at the dosage of 25 mJ per cm2. To study the
effects of Ca21, the cells were cultured with 1.8 mM of Ca21 for 12 and
24 h as described in the section of cell treatments in the keratinocyte SFM
medium. Northern blotting was done as described before (Funasaka et al,
1998). Briefly, total cellular RNAs (50 µg) were size-fractionated on 1.0%
agarose/formaldehyde gels and blotted on to cellulose nitrate membrane
(Schleicher and Schuell, Dassel, Germany). The blots were prehybridized
in 40% formamide/10% Denhardt’s solution/4 3 sodium citrate/chloride
buffer/7 mM Tris–Cl, pH 7.4/sheared 20 µg per ml salmon sperm DNA,
Figure 1. Expression of a-MSH and ACTH in normal human skin.
Arrow indicates the differentiated keratinocytes of the uppermost portion
of Malpighian layer expressed immunoreactive α-MSH and ACTH. Scale
bar: 100 µm.
Figure 2. Immunostaining for involucrin
during Ca21, and UVB treatment of
normal human keratinocytes. Treatment
and staining procedure as described in Materials
and Methods. (A) Ca21 and (B) UVB,
both induce the expression of involucrin, a
differentiation marker, by normal human
keratinocytes.
for 1 h at 42°C and hybridized at 42°C overnight with the coding region
of hMC1-R, cloned from a human genomic EMBL3 phage library (Gantz
et al, 1993a) which was random prime-labeled with [α-32-P] dCTP
(Amersham, Arlington Heights, IL). The membranes were washed in
2 3 sodium citrate/chloride buffer, 0.1% sodium dodecyl sulfate for 15 min
twice at room temperature and 0.1 3 sodium citrate/chloride buffer, 0.1%
sodium dodecyl sulfate for 30 min twice at 65°C, and then exposed to a
phosphor-imaging plate for 1 h. The total radioactivity of each hybridized
bands was quantitated using a Fujix Bio-Image analyzer BAS2000 (Fuji
Photo Film, Kanagawa, Japan). To get the internal control, the membranes
were rehybridized with human β-actin cDNA (Clontech, Palo Alto,
CA) random prime-labeled [α-32P] dCTP. MC1-R mRNA levels were
normalized using β-actin mRNA signals and its PhosphorImager count
ratios were calculated. Autoradiogram was developed by exposing X-ray
film to the membrane at –75°C for 1–3 d.
RESULTS
Expression of ACTH and MSH peptides in skin specimens
In normal skin, α-MSH and ACTH, were expressed in keratino-
cytes with accentuation in the more differentiated keratinocytes of
the uppermost portion of Malpighian layer (Fig 1). No specific
staining was seen in control sections when normal rabbit serum
was used instead of specific POMC antibodies (not shown).
Morphologic changes in differentiated keratinocytes induced
by Ca2F treatment or UVB irradiation Undifferentiated fore-
skin keratinocytes exhibited typical morphology. After culturing
the cells in a medium, which contains 1.8 mM Ca21, signs of
differentiation could be seen as early as 12 h, and it became obvious
after 24 h. At the first stage of differentiation, the proliferation of
these Ca21-treated cells slowed down, and stratification was
observed under light microscope (data not shown). Immunostaining
with monoclonal antibody specific for differentiation marker invo-
lucrin (Watt and Green, 1982) showed that involucrin was expressed
in about 50% of cells that were treated with Ca21 for 12 h. This
percentage increased to 90% at 24 h indicating that cells have
undergone differentiation (Fig 2).
From our experience of UVB treatment on keratinocytes the
most effective dose of UVB was 25 mJ per cm2 for induction of
POMC peptides expression (Chakraborty et al, 1996). Therefore,
in this experiment we irradiated normal human keratinocytes with
25 mJ per cm2 of UVB, and after 24 h we noticed that both the
intensity of involucrin staining and the number of positively stained
cells were markedly increased over those of control cells (Fig 2).
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Table I. Effects of Ca2F and UVB on a-MSH and ACTH synthesis and release by normal human keratinocytesa
α-MSH ACTH
Cellular Medium Cellular Medium
Treatment (pg per 0.5 3 106 cells) (pg per ml) (pg per 0.5 3 106 cells) (pg per ml)
None 32.5 6 7.1 11.7 6 1.3 20.6 6 2.6 8.1 6 1.8
Ca21 (1.8 mM) 30.2 6 4.7 24.9 6 17.7* 14.6 6 6.4 12.5 6 3.4*
UVB (25 mJ per cm2) 57.3 6 1.1** 32.8 6 2.5* 52.3 6 3.1** 21.8 6 2.1**
aα-MSH and ACTH were measured using a commercial radioimmunoassay kit. Values of α-MSH and ACTH content were normalized to cell number and expressed as
pg per 0.5 3 106 cells (intracellular level); pg per ml medium (released to the medium). Each data point represents the mean 6 SD of two assays from a representative
experiment. The experiments were repeated three times with similar results. The statistical analysis of these data were done using the two-tailed paired t-test (Abacus,
STATVIEW Program). *p , 0.05, **p , 0.001.
Effect of Ca2F and UVB on production and release of MSH
and ACTH by normal human keratinocytes During Ca21-
induced differentiation, the secretion of α-MSH and ACTH by
normal human keratinocytes was stimulated in culture (Table I).
No significant changes in intracellular level of POMC peptides
were observed in Ca21-treated cells, whereas UVB stimulated both
production and secretion of peptides by keratinocytes in culture.
POMC mRNA expression Semiquantitative reverse transcrip-
tion–PCR assay (30 cycles) showed that during Ca21-induced
differentiation there was no significant change in the expression of
a 260 bp product of POMC transcript in normal human keratino-
cytes in culture; however, UVB upregulated POMC mRNA
expression (Fig 3). The size of the product was equal to that
predicted from primer sequences, and migrated identically with a
POMC transcript run in parallel as a positive control (not shown).
The concentration of the amplified fragment of the β-actin tran-
script, used as an internal control, remained unchanged during the
treatment, and no product was found in control RNA samples
amplified without previous reverse transcription. We conclude that
the amplified 260 bp product representing exon 3 of the POMC
gene are unchanged by Ca21 treatment but increased by UVB.
These results are in agreement with the earlier reports (Schauer
et al, 1994; Slominski et al, 1995; Chakraborty et al, 1996).
MSH receptor activity and mRNA expression Preliminary
experiments with normal human keratinocytes in culture showed
that the keratinocytes have specific MSH binding ability. In the
next experiment shown in Table II we determined that the MSH
receptor activity can be increased by Ca21 and UVB treatment of
keratinocytes in culture (Table II).
Semiquantitative reverse transcription–PCR assay (30 cycles)
showed that both UVB and Ca21 stimulated the expression of
580 bp product of MSH receptor (MC1-R) transcript, whereas no
significant changes were found in the concentration of amplified
fragment of β-actin used as an internal control. Similar conclusions
were obtained from northern blotting experiment of MC1-R after
Ca21 and UVB treatment. The α-MSH receptor mRNA transcript
migrated as a 4 kb species, as reported previously (Mountjoy et al,
1992), and that, too, was stimulated in human keratinocyte by
Ca21 and UVB treatment (Fig 4).
DISCUSSION
The melanotropin receptors represent a subfamily of G-protein-
coupled receptors with seven transmembrane domains, and in
human melanocytes a 3 kb and 4 kb mRNA species specific for
MC1-R have been reported (Cone et al, 1993). By northern blot
analysis, however, we detected expression of MC1R, a 4 kb
mRNA species, in normal human keratinocytes. The human
MC1-R differs markedly from its murine counterpart in its high
affinity for ACTH (Chhajlani and Wikberg, 1992; Mountjoy et al,
1992; Suzuki et al, 1996). So far, five different melanocortin
receptors (MC1-R–MC5-R) have been cloned and found to differ
in their tissue distribution and relative affinities for the various
melanotropic peptides (Chhajlani and Wikberg, 1992; Mountjoy
et al, 1992; Gantz et al, 1993a, b; Roselli-Rehfuss et al, 1993; Labbe
Figure 3. Detection of POMC mRNA by semiquantitative reverse
transcription–PCR in normal human keratinocytes treated with
UVB and Ca21. Upper panel: 260 bp POMC mRNA from exon 3 (arrow)
was amplified (30 cycles) using primers described in Materials and Methods.
Lower panel shows amplification of β-actin gene as control. DNA size
marker, M; untreated human keratinocytes (lane 1); human keratinocytes
exposed to UVB, 25 mJ per cm2 (lanes 2 and 3), and 50 mJ per cm2 (lanes
4 and 5) after 12 h (lanes 2 and 4) and 24 h (lanes 3 and 5); human
keratinocyte treated with 1.8 mM Ca21 for 12 h (lane 6) and 24 h (lane 7).
et al, 1994). Until recently, the cloned human MC1-R has been
reported to be expressed exclusively in normal and malignant
melanocytes (Mountjoy et al, 1992; Chhajlani and Wikberg, 1992;
Suzuki et al, 1996). Gradually, the evidence is building that MC1-R
exists in other cell types, including monocytes (Rajora et al, 1996;
Bhardwaj et al, 1997), endothelial cells (Hartmeyer et al, 1997),
and dermal fibroblasts2 (Boston and Cone, 1996). With regard to
the skin, a radioligand binding assay on immortalized human
epidermal keratinocytes has demonstrated that these cells show
binding affinity for β-MSH (Chakraborty and Pawelek, 1993),
whereas Suzuki et al (1996) were unable to detect specific mRNA
transcripts for MC1-R in normal human keratinocytes, and
immunostaining of normal skin has also failed to identify any
MC1-R protein in keratinocytes in vivo (Xia et al, 1995). The
study of Chakraborty and Pawelek, however, is in close agreement
with several recent reports from different laboratories that normal
human keratinocytes express both POMC peptides and at least
some of the POMC-peptide receptors, MC1-R1 (Bhardwaj and
Luger, 1994; Jiang et al, 1997; Orel et al, 1997). Although at
present, the reason for this apparent contradiction remains unclear,
it should be mentioned that not all cultures of human melanocytes
2Bohm M, Schulte U, Hartmeyer M, Scholzen T, Becher E, Luger TA:
Human dermal fibroblasts express melanocortin-1 receptors and respond
to α-melanocyte stimulating hormone with secretion of interleukin-6 and
interleukin-8. J Invest Dermatol 108:593, 1997 (abstr.)
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Table II. Effect of Ca2F and UVB on MSH receptor
binding activity of normal human keratinocytesa
125I-α-MSH binding activity
Treatment in culture (Specific binding per 105 cells) % of control
None 233 6 11 100 6 15
Ca21 (1.8 mM)
12 h 363 6 46* 158 6 39
24 h 459 6 23* 197 6 10
UVB (25 mJ per cm2) 696 6 32** 275 6 34
aNormal human keratinocytes were cultured with Ca21 (1.8 mM) or exposed to
UVB (25 mJ per cm2). Twelve and 24 h (Ca21 treatment) and 24 h (UVB) later
the cells were washed with PBS(–), and 125I-α-MSH binding assays were carried
out as described in Materials and Methods. Values (mean 6 SD) from three separate
experiments done in triplicate are expressed as percentage of control specific binding.
*p , 0.05; **p , 0.001.
are responsive to MSH (Hunt et al, 1994a, b). Iwata et al (1990)
demonstrated that NDP-MSH failed to stimulate tyrosinase activity
in 50% of human foreskin organ cultures, and that responsiveness
was unrelated to the racial origin of the skin. Further the discovery
of different subtypes of the melanocortin receptor and their coupling
to multiple effector systems (see for review Milligan, 1993; Konda
et al, 1994; Lu et al, 1998) makes the situation complicated until
more information is gathered.
In fact, by a semiquantitative reverse transcription–PCR assays we
observed that in addition to MC1-R, normal human keratinocytes
express MC4-R (Funasaka et al, unpublished data). Whereas
MC1-R is specific for pigmentation, MC4-R is known for
regulation of feeding, metabolism, and thermoregulation. It is
expressed mainly in the brain (see for review Lu et al, 1998). Both
receptors have similar ligand binding affinity for α-MSH. The
functional relevance of MC4-R in the skin, however, is not
known yet.
The expression of POMC peptides and melanocortin receptors
in the epidermal melanin unit, melanocytes and keratinocytes, and
homologous upregulation of MSH receptor by ligand binding
(Chakraborty and Pawelek, 1992, 1993; Siegrist et al, 1994; Jiang
et al, 1996; Suzuki et al, 1996), suggest a physiologic role of these
hormones in regulating human pigmentation and immune responses
in both autocrine and paracrine manners. In fact, α-MSH and
other POMC peptides were found to modulate proliferation and
differentiation (Slominski et al, 1991; 1993b) as well as heat shock
protein expression (Orel et al, 1997) of normal human keratinocytes
indicating the involvement of such receptors in response to melano-
tropic peptides.
In order to determine the role of melanocortin receptor subtypes
in mediating the various effects of melanocortins in keratinocytes,
antagonists are essential tools, but thus far, to our knowledge, no
good subtype specific antagonists are available. The cloning of the
melanocortin receptors, however, has provided new opportunities
for the development of selective agonists and antagonists by way of
mapping the sites of action on the different subtypes of the receptor.
With regard to UV-induced melanogenesis specifically, UV
irradiation has been shown to increase MSH receptor expression
and MSH binding in murine melanoma cells (Bolognia et al, 1989;
Chakraborty et al, 1991; Eller et al, 1996) and in normal human
melanocytes (Funasaka et al, 1998). Apparently similar increases of
MSH receptor expression and MSH binding have been observed
in response to thymidine dinucleotides added to the medium or to
DNA damage in these cells (Eller et al, 1996). In this study we
have shown that normal human keratinocytes also express MSH
receptors that can be induced by UVB irradiation as well as during
Ca21-induced differentiation. Taken together the fact that the
melanotropins are synthesized and secreted by keratinocytes in
response to UVB irradiation (Schauer et al, 1994; Chakraborty et al,
1996; Wintzen et al, 1996) and synthesized during differentiation
(this study) suggests that these hormones might have a paracrine
role in regulating human pigmentation and response to solar
radiation and other inflammatory stimuli.
Figure 4. Expression of MC1-R gene by normal human
keratinocytes after UVB and Ca treatment. (a) Detection of MC1-R
mRNA by semiquantitative reverse transcription–PCR in normal human
keratinocytes treated with UVB and Ca21. Upper panel: 580 bp MC1-R
mRNA (arrow) was amplified (30 cycles) using primers described in Materials
and Methods. Lower panel shows amplification of β-actin gene. DNA size
marker, M; untreated human keratinocytes (lane 1); human keratinocytes
exposed to UVB, 25 mJ per cm2 (lanes 2 and 3), and 50 mJ per cm2 (lanes
4 and 5) after 12 h (lanes 2 and 4) and 24 h (lanes 3 and 5); human
keratinocyte treated with 1.8 mM Ca21 for 12 h (lane 6) and 24 h (lane
7). (b) Northern blotting of MC1-R (upper panel) and β-actin (lower panel).
Untreated human keratinocytes (lane 1); human keratinocytes exposed to
UVB, 25 mJ per cm2 after 12 h (lane 2) and 24 h (lane 3); human
keratinocytes treated with Ca21 for 12 h (lane 4) and 24 h (lane 5).
Although it is not well understood yet how or even whether
MSH modulates keratinocyte function, several recent reports docu-
ment the actions of melanotropins on proliferation (Slominski et al,
1991) as well as on heat shock protein expression (Orel et al, 1997)
of normal human keratinocytes indicating the involvement of
such receptors in normal human keratinocytes in response to
melanotropic peptides.
In epidermal keratinocytes in vitro, Ca21 is an important inducer
of terminal differentiation characterized by synthesis of involucrin,
a precursor of cornified envelope (Rice and Green, 1979;
Rheinwald and Beckett, 1981; Watt, 1983; Fuchs, 1993). Various
exogenous agents or cell manipulations have been shown to
stimulate terminal differentiation as well. Among these are 12-O-
tetradecanoyl-phorbol-13-acetate, vitamin D3, retinol depletion,
and UVB irradiation (Fuchs, 1993; Watt et al, 1988; Matsui et al,
1996). The mechanisms involved in keratinocyte differentiation
are not well understood. Modulation of receptor-associated kinase
activity has been shown to participate in differentiation, as
exemplified by the differentiating effect of 12-O-tetradecanoyl-
phorbol-13-acetate on keratinocytes via activation of protein kinase
C activity (Matsui et al, 1996).
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In our experiments, we observed that increased involucrin
synthesis in normal human keratinocytes after high Ca21 treatment
and UVB irradiation is consistent with their progression to a
terminally differentiated state associated with cornified envelope
formation. The differentiation process in UV-irradiated keratino-
cytes, however, may be specific and independent of the Ca21
concentration, because UVB irradiation was shown to cause cell
cycle arrest and/or induce the formation of aptotic keratinocytes
(Zhan et al, 1993).
The epidermis is exposed to a variety of injurious environmental
conditions such as UV or ionizing radiation, hyperthermia, heavy
metals or certain metabolic poisons (Parsell and Lindquist, 1994;
Simon et al, 1995) that can cause acute and chronic adverse effects
on skin including dermatitis, skin cancer, and skin aging (Cerutti,
1985; Darr, 1988; Fuchs and Packer, 1991). A unique feature of
the epidermis is that it consists of stratified gradient of continuously
more differentiated keratinocyte cells (Eckert, 1989; Fuchs, 1990)
which produce cytoprotective heat shock proteins and develop
resistance to oxidative stress (Trautinger et al, 1993; Maytin, 1995).
As α-MSH was found to downregulate heat shock protein 70 in
keratinocytes and renders them more sensitivity to oxidative stress
(Orel et al, 1997), our findings of the upregulated expression of
POMC peptides and their specific receptors in keratinocytes during
differentiation may indicate a crucial role of POMC network in
the modulation of the epidermal stress response as well as of
inflammatory reactions. The epidermal–melanin unit is composed
of melanocytes and keratinocytes, and the activity of this unit is
observed, for example, when melanin is donated from the melano-
cytes to surrounding keratinocytes in response to UV light. A clue
to the possible mechanism for mutual control of this unit may lie
in the expression of MSH receptors. Our findings, the existence
of MSH receptors and their enhanced expression in normal human
keratinocytes during differentiation induced by exogenous agents
like Ca21 and UVB, are consistent with a model in which the
UV-mediated release of POMC peptides and UV-mediated increase
in MSH receptor activity could initiate UV responses in both
keratinocytes and melanocytes in a coordinated fashion (Pawelek
et al, 1992; Chakraborty et al, 1995, 1996). The work of Gilchrest
and coworkers supports this hypothesis of melanocyte and keratino-
cyte interaction (Gordon et al, 1989).
POMC-derived peptides are well appreciated for their diverse
regulatory functions (Autelitano et al, 1989). Of particular interest
for melanoma biology are: regulation of the differentiated phenotype
and proliferation by MSH and ACTH (Lunec et al, 1990) and
immunomodulatory functions of β-endorphins, corticotropins, and
melanotropins (Blalock, 1989; Bhardwaj et al, 1997). It is generally
accepted that malignant behavior of solid tumors is the result
of complex multidirectional interactions between different cell
populations including cells of the immune system. Therefore, the
POMC expression in melanomas could imply the existence of
autoregulatory loops governing the phenotype and malignancy of
melanomas which would involve autocrine and paracrine regulation
as well as a cross-talk between melanoma cells and cells of the
immune system. The UVB-mediated stimulation of expression of
POMC and MC1-R in keratinocytes may occur in two ways:
direct activation by producing active oxygen species and/or DNA
damage, or an indirect one that involves various intermediary
effector compounds like cytokines, growth factors, etc., produced
in and released from epidermal cells. Although we observed no
significant change of MC1-R expression in 1–3 h, but in the 12–
24 h time period after UVB irradiation, it does not necessarily
mean that the effect of UVB in this regard is exclusively via a
paracrine mechanism, but it includes a direct effect too, as the
active oxygen species and/or DNA dimers produced in direct
mechanism, may require 12–24 h to induce the expression of
MC1-R/POMC (Chakraborty et al, 1996). Furthermore, as UVB
induces secretion of various cytokines, growth factors, neuropep-
tides, etc., it would be interesting to screen all these compounds
which are involved, if at all, in the UVB-mediated response. This
mechanistic question, although important is beyond the scope of
this work, which was designed to show evidence of increased
localization of POMC peptides near differentiated keratinocytes of
the epidermis is whether due to increased expression of MC1-R
and/or their increased binding ability. Of course, our future goal
is to dissect the mechanisms of UVB-mediated increase of POMC
and its receptor expression in melanocytes and keratinocytes.
In conclusion, normal human keratinocytes express MSH recep-
tors, and the stronger expression of POMC peptides on the
suprabasal layer of the epidermis where the keratinocytes are mostly
differentiated, seems to be due to the stronger binding ability of
the receptor, although it is not clear yet whether this stronger
binding ability is due to any change in receptor number or affinity.
Nevertheless, this work further provides evidences to support a
mechanism in the skin for a regulated response of UV signals that
are then transduced to initiate the cascade of ensuing cellular
enzymatic events.
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